Search Results - "Westbrook, K. E."

Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma by Thornton, M. J., Williamson, H. V., Westbrook, K. E., Greenup, R. A., Plichta, J. K., Rosenberger, L. H., Gupta, A. M., Hyslop, T., Hwang, E. S., Fayanju, O. M.

“…Background Neoadjuvant chemotherapy (NACT) is often recommended for patients with node-positive invasive lobular carcinoma (ILC) despite unclear benefit in…”
Get full text

Abstract P6-04-11: The foundation one assay influences clinical decision making in metastatic breast cancer by Harnden, KK, Kimmick, GG, Marcom, PK, Westbrook, KE, Blackwell, KL

“…Background: Tumor DNA sequencing is now readily available in metastatic breast cancer (MBC). The purpose of this study was to determine the effect of molecular…”
Get full text

Abstract P3-12-02: Predictors of adherence to adjuvant endocrine therapy (ET) for early breast cancer (BC) in a prospective clinic-based cohort by Smith, KL, Yeruva, SLH, Blackford, A, Huang, C-Y, Westbrook, KE, Harding, BA, Smith, A, Fetting, J, Wolff, AC, Jelovac, D, Miller, RS, Connolly, R, Armstrong, D, Nunes, R, Visvanathan, K, Stearns, V

“…Background: Adjuvant ET is associated with improved survival in women with hormone receptor-positive early BC. Nonetheless, more than a quarter of women are…”
Get full text